Yew Bio Pharm Income Statement - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.3 $0 (0%) YEWB stock closing price Dec 02, 2016 (Closing)

Fundamental analysis of YEWB stock involves analyzing its financial statements, apart from checking the Yew Bio Pharm stock price In the income statement, an investor can check for important parameters like the topline, the bottomline, the EPS basic, dividends etc. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from $16.06M to $14.67M and how operating and non operating activities have impacted the YEWB stock. Along with Yew Bio Pharm assets and Yew Bio Pharm free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have decreased from $1.31M QoQ and 2016-Q3 revenue is $14.67M. View details of revenue and profits for Yew Bio Pharm for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Yew Bio Pharm Net Sales or Revenues
14.67M16.06M8.62M17.27M5M4.67M2.64M1.9M1.7M2.06M
Cost Of Goods Sold (COGS)13.24M14.41M7.22M15.52M3.57M2.28M1.17M0.9M0.29M0.42M
Yew Bio Pharm Gross Profit
1.41M1.64M1.39M1.78M1.41M2.37M1.47M1.01M1.4M1.63M
Research & Development Expense----------
Selling General & Admin Expense0.29M0.34M0.31M0.46M0.48M0.48M0.47M0.41M0.51M0.22M
Income Before Depreciation Depletion Amortization1.11M1.3M1.07M1.32M0.93M1.89M0.99M0.61M0.89M1.41M
Depreciation Depletion Amortization----------
Non Operating Income-0.03M--0.02M0.05M-0.11M----
Interest Expense----------
Yew Bio Pharm Pretax Income
1.08M1.3M1.05M1.38M0.93M2M0.99M0.61M0.89M1.41M
Provision for Income Taxes----0.04M--0.04M---
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations1.08M1.31M1.05M1.39M0.93M2.01M0.96M0.61M0.89M1.41M
Extraordinary Items & Discontinued Operations----------
Yew Bio Pharm Net Income (Profit/Loss)
1.08M1.31M1.05M1.39M0.93M2.01M0.96M0.61M0.89M1.41M
Average Shares used to compute Diluted EPS51.89M51.88M51.88M51.88M52.19M57.62M58.23M---
Average Shares used to compute Basic EPS51.88M51.88M51.88M51.88M52.16M52.13M52.13M---
Income Before Nonrecurring Items1.08M1.31M1.05M1.39M0.93M2.01M0.96M---
Income from Nonrecurring Items----------
Yew Bio Pharm Earnings Per Share Basic Net
0.020.030.020.030.020.040.02---
Yew Bio Pharm Earnings Per Share Diluted Net
0.020.030.020.030.020.030.02---
EPS Diluted Before Nonrecurring Items0.020.030.020.030.020.030.02---
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

It is very helpful to read a report on Yew Bio Pharm stock analysis. An investor must check the following items in an income statement:
  • Topline: A growing topline, as seen from the Yew Bio Pharm revenue chart, as is not the case with Yew Bio Pharm indicates a sagging business. One needs to compare the QoQ or YoY topline growth of YEWB stock with its peers like MRGO stock and CMCI stock to see if the growth compares well with what can be expected for a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $1.08M for Yew Bio Pharm for 2016-Q3. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Yew Bio Pharm historical stock prices to check how the price has moved with time. .

Yew Bio Pharm Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
3.0000
PS ratio (
price sales ratio
)
0.2748
Operating margin
8.1
Net profit margin
8.2
Dividend yield
0%